Foresee Pharmaceuticals has shown that a long-acting version of its injectable prostate cancer med Camcevi can help patients ...

A specialty pharmacy in Waltham announced a voluntary recall Sunday of compounded medications shipped over the past three months.Village Fertility Pharmacy said they decided to pull the medications ...

The probability of survival at 8 years was an unprecedented 78.9% with XTANDI plus leuprolide versus 69.5% with leuprolide, in men with non-metastatic hormone-sensitive prostate cancer with high-risk ...

Learn everything you need to know about Leuprolide-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Leuprolide (Lupride) is a gonadotropin-releasing ...

This open-label study evaluated the efficacy and safety of a new leuprolide acetate 45 mg 6-month depot formulation in 151 men with prostate cancer who received 2 intramuscular injections administered ...

According to SNS Insider, the Leuprolide Acetate Market size was valued at USD 2.92 billion in 2024 and is projected to reach USD 4.43 billion by 2032, reflecting a compound annual growth rate (CAGR) ...